Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients.
Journal: Translational behavioral medicine
Published: June 08, 2026
Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.
Journal: CA: a cancer journal for clinicians
Published: March 31, 2026
Benign but burdensome: Complications and management of benign prostatic hyperplasia during active surveillance of prostate cancer in a large cohort.
Journal: Urologic oncology
Published: February 25, 2026
Determining Barriers to Dietary Change Among Medically Underserved Men With Prostate Cancer.
Journal: Health education & behavior : the official publication of the Society for Public Health Education
Published: February 25, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
Journal: The Journal of urology
Published: February 09, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
Journal: The Journal of urology
Published: February 09, 2026
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.
Journal: JCO oncology practice
Published: November 07, 2025
The intersection of race and adiposity in prostate cancer: a narrative review.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: September 08, 2025
Metabolic syndrome is associated with increased mortality in patients with breast or prostate cancer.
Journal: Scientific reports
Published: June 27, 2025
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patients.
Journal: Future oncology (London, England)
Published: April 01, 2025
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer.
Journal: European urology
Published: January 07, 2025
Last Updated: 09/26/2026